These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 17089921

  • 1. Omalizumab for severe asthma?
    Drug Ther Bull; 2006 Nov; 44(11):86-8. PubMed ID: 17089921
    [Abstract] [Full Text] [Related]

  • 2. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD, Turk F.
    Allergy; 2008 Jun 08; 63(6):670-84. PubMed ID: 18445184
    [Abstract] [Full Text] [Related]

  • 4. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A, Sternon J.
    J Pharm Belg; 2006 Jun 08; 61(3):83-7. PubMed ID: 17058881
    [Abstract] [Full Text] [Related]

  • 5. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D.
    Respir Med; 2006 Nov 08; 100(11):1907-17. PubMed ID: 16949266
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep 08; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

  • 8. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P, Hauser C, Rochat T.
    Rev Med Suisse; 2007 Apr 25; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [Abstract] [Full Text] [Related]

  • 9. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P, Sauty A, Rochat T.
    Rev Med Suisse; 2007 Jan 10; 3(93):56-9. PubMed ID: 17354662
    [Abstract] [Full Text] [Related]

  • 10. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD.
    Allergy; 2005 Mar 10; 60(3):302-8. PubMed ID: 15679714
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Omalizumab (Xolair). Product description].
    Laursen LC.
    Ugeskr Laeger; 2007 Mar 12; 169(11):993-5. PubMed ID: 17371630
    [Abstract] [Full Text] [Related]

  • 13. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S, Richter D, Cepelak I, Benko B.
    Acta Pharm; 2005 Jun 12; 55(2):123-38. PubMed ID: 16179127
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Treatment of severe asthma with anti-immunoglobulin E (Omalizumab). A new possibility in pulmonary medicine].
    Nolte H, Harving H, Backer V.
    Ugeskr Laeger; 2007 Dec 10; 169(50):4366-7. PubMed ID: 18211797
    [Abstract] [Full Text] [Related]

  • 20. Technology evaluation: omalizumab, Genentech/Novartis/Tanox.
    Lazaar AL.
    Curr Opin Mol Ther; 2003 Feb 10; 5(1):81-9. PubMed ID: 12669476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.